MARKET

PHVS

PHVS

Pharvaris N.V.
NASDAQ
27.48
+0.47
+1.74%
After Hours: 27.48 0 0.00% 16:10 02/10 EST
OPEN
26.76
PREV CLOSE
27.01
HIGH
27.50
LOW
25.69
VOLUME
91.64K
TURNOVER
--
52 WEEK HIGH
29.80
52 WEEK LOW
11.51
MARKET CAP
1.79B
P/E (TTM)
-8.0142
1D
5D
1M
3M
1Y
5Y
1D
Pharvaris präsentiert positive Phase-3-Daten zu Deucrictibant bei HAE auf AAAAI-Kongress
Reuters · 22h ago
Pharvaris Unveils Positive Phase 3 RAPIDe-3 Data for Deucrictibant in HAE Treatment
Reuters · 22h ago
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Erasca (ERAS) and Pharvaris (PHVS)
TipRanks · 1d ago
Weekly Report: what happened at PHVS last week (0202-0206)?
Weekly Report · 2d ago
Morgan Stanley Reaffirms Their Buy Rating on Pharvaris (PHVS)
TipRanks · 02/02 13:57
Weekly Report: what happened at PHVS last week (0126-0130)?
Weekly Report · 02/02 09:03
Bank of America Securities Keeps Their Hold Rating on Pharvaris (PHVS)
TipRanks · 01/27 13:28
Assessing Pharvaris (PHVS) Valuation After Earnings Beat And Renewed Analyst Optimism
Simply Wall St · 01/27 03:25
More
About PHVS
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.

Webull offers Pharvaris NV stock information, including NASDAQ: PHVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHVS stock methods without spending real money on the virtual paper trading platform.